Related Experiment Video
Updated: Apr 27, 2026

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity
Published on: December 31, 2015
MACC1 induces metastasis in ovarian carcinoma by upregulating hepatocyte growth factor receptor c-MET
Xiu-Jie Sheng1, Zhen Li1, Man Sun1
1Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510150, P.R. China.
Abstract:
Metastasis-associated in colon cancer 1 (MACC1) is a newly identified gene that has been shown to promote tumor cell invasion and metastasis. The present study investigated the effect of MACC1 downregulation on the biological characteristics of the ovarian cancer OVCAR3 cell line. In this study, MACC1 expression was blocked using the RNA interference technique. The downregulation of MACC1 mRNA and protein expression was confirmed using quantitative polymerase chain reaction and western blot analysis. The proliferative activity and adhesion rate of the cells were detected using cell counting kit-8 and a cell adhesion assay, while cell invasion was determined using a Matrigel invasion assay and migration capacity was observed using migration and wound-healing assays. A tube formation assay was also used to examine the angiogenic capacity of cells, and a luciferase assay was performed to assess whether MACC1 binds to the c-MET gene. The MACC1 mRNA and protein expression levels were significantly downregulated using sequence-specific small interfering RNA (siRNA). The inhibition of MACC1 expression markedly decreased the invasive, metastatic and angiogenic capacities of the cells, but only slightly inhibited growth and adhesion. In addition, a putative MACC1-binding site was identified in the 3'-untranslated region of c-MET. MACC1-siRNA was also found to significantly reduce the expression of the c-MET protein and a luciferase reporter assay confirmed that c-MET was the target gene of MACC1. These results demonstrated that the attenuation of MACC1 suppresses cell invasion and migration and that MACC1 may regulate cell metastasis through targeting the expression of c-MET. Inhibition of the function of MACC1 may represent a new strategy for treating ovarian cancer.
Insights
Metastasis-associated in colon cancer 1 (MACC1) gene silencing reduced ovarian cancer cell invasion and metastasis. MACC1 targets c-MET, suggesting MACC1 inhibition as a potential ovarian cancer treatment strategy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Metastasis-associated in colon cancer 1 (MACC1) is implicated in tumor invasion and metastasis.
- Ovarian cancer progression involves complex cellular mechanisms including invasion and metastasis.
Purpose of the Study:
- To investigate the functional role of MACC1 in ovarian cancer.
- To determine the effect of MACC1 downregulation on OVCAR3 cell biological characteristics.
- To explore the relationship between MACC1 and the c-MET gene.
Main Methods:
- RNA interference (siRNA) was used to downregulate MACC1 expression in OVCAR3 cells.
- Quantitative PCR and Western blot confirmed MACC1 knockdown.
- Cell proliferation, adhesion, invasion, migration, angiogenesis, and c-MET interaction were assessed.
Main Results:
- MACC1 downregulation significantly reduced ovarian cancer cell invasion, migration, and angiogenesis.
- MACC1 inhibition had minimal impact on cell proliferation and adhesion.
- MACC1 was confirmed to target and reduce c-MET protein expression.
Conclusions:
- MACC1 downregulation suppresses ovarian cancer cell invasion and metastasis.
- MACC1 regulates cancer cell metastasis potentially by targeting c-MET.
- Inhibiting MACC1 function presents a novel therapeutic strategy for ovarian cancer.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mitogens and the Cell Cycle

